Target intelligence / Profile preview

Crystallin (CRY)

Target
CRY
Molecular classification
Small heat shock protein [1, 11], Molecular chaperone [1, 12], Structural protein [13, 15], Enzyme [5, 13]
01

Overview

Crystallins are a major class of water-soluble structural proteins that constitute the majority of the vertebrate eye lens and cornea, where they are essential for maintaining transparency and a high refractive index [13, 15]. They are categorized into three main families: alpha, beta, and gamma crystallins. Alpha-crystallins, comprising alpha-A (CRYAA) and alpha-B (CRYAB) subunits, belong to the small heat shock protein (sHSP) family and function as molecular chaperones that prevent the non-specific aggregation of misfolded proteins [1, 11]. Beta and gamma crystallins primarily serve structural roles but also participate in calcium signaling and UV protection [11, 13]. The misfolding and subsequent aggregation of these proteins into insoluble amyloids is the primary cause of cataracts, the leading cause of blindness globally [3, 10]. Beyond the ocular lens, alpha-B crystallin is widely expressed in tissues such as the heart, brain, and skeletal muscle, where it plays roles in neuroprotection, muscle contraction, and the inhibition of apoptosis [6, 12]. In cancer, alpha-B crystallin is often overexpressed and acts as a 'malignant chaperone,' promoting tumor cell survival and resistance to chemotherapy by inhibiting pro-apoptotic pathways [6]. Therapeutic development focuses on pharmacological chaperones, such as lanosterol and oxysterol derivatives (e.g., VP1-001), which aim to stabilize the native protein structure and reverse aggregation in cataracts [8, 9]. Additionally, mini-chaperone peptides derived from alpha-crystallin are being explored for their potential to treat neurodegenerative and inflammatory diseases [7, 14].

Other names
Lens crystallinAlpha-crystallinBeta-crystallinGamma-crystallinCRYAACRYABHspB4HspB5Small heat shock protein
02

Mechanism of action

Pharmacological chaperone that binds to and stabilizes the native or soluble forms of crystallin proteins, preventing or reversing their aggregation into insoluble amyloids [3, 8]. It also acts as a chaperone mimetic to inhibit apoptosis and protect cells from oxidative stress [1, 6].

03

Biological functions

Maintenance of lens transparency and refractive index [13, 15]Molecular chaperone activity [1, 11]Inhibition of apoptosis [6, 12]Regulation of signal transduction pathways [1, 12]Stabilization of the cytoskeleton [12]Protection against oxidative and thermal stress [1, 15]
04

Disease associations

Cataract [3, 10]Neurodegenerative disease [1, 5]Cancer [6, 15]Cardiovascular disease [1, 12]Inflammation [1, 15]
05

Safety considerations

Potential to promote tumor survival and chemoresistance due to anti-apoptotic activity [6]Off-target effects in the heart, brain, and skeletal muscle [1, 12]Bioavailability and stability challenges for peptide-based chaperones [14]Limited solubility and efficacy of certain sterol-based compounds [10]
06

Interacting drugs

Lanosterol [8, 10]

5 more in the full profile.

07

Biomarkers

Lens Opacities Classification System III (LOCS III) grade [8]Soluble-to-insoluble protein ratio in the lens [3]Alpha-B crystallin (CRYAB) expression levels [6, 12]

Beyond the preview

Go deeper on Crystallin (CRY).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crystallin (CRY).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call